PATENT CLAIM ANALYSIS

Application Number: 15990547
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-01
Patent Classification: ["514", "04400A"]

Abstract:
The application discloses methods and compositions for the inhibition of the alternative complement pathway. The methods and compositions involve the use of aptamers for inhibiting complement Factor D. The application further provides anti-Factor D aptamers for the treatment of dry age-related macular degeneration, geographic atrophy, wet age-related macular degeneration or Stargardt disease. In some cases, stem-loop aptamers are provided for the inhibition of Factor D.

Claim (Index 16):
The aptamer of  claim 1 , wherein said aptamer is an RNA aptamer comprising nucleotides having ribose in a \u03b2-D-ribofuranose configuration.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 93.0
- Lexical Diversity: 1.69048
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15693361', '15990542', '14347738', '14646104', '11990998']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7242569134100111
- 35 USC 102 Novelty (BERT): 0.5424696023910557
- Combined Prediction Score: 0.7060781823081156
- Mean Citation Score: 268.163888
- Max Citation Score: 373.8787
- Similarity Product: 289.88652857184417

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test